Recently, a patent invalidity case between Medtronic PLC and Jiangsu Niko Medical Devices Co., Ltd., represented by Sunshine Intellectual Property International Co., Ltd. and Beijing Yiju Law Firm, was closed. China National Intellectual Property Administration made the invalidation examination decision No. 60422, which ruled patent No. 201710388962.2, Medtronic’s "device for intravascular intervention" as invalid.
Founded in 1949, Medtronic PLC is one of the largest medical device manufacturers in the world with over 95,000 employees. Medtronic ranks 473 on “2022 Fortune Global 500”, 96 on “2022 The Hurun Global 500”, and 1st on “2022 Medtech Big 100”.
